“…Hyperinfection and dissemination carry significant morbidity and mortality with fatality rates reaching 85% (5,6,19). Hyperinfection and dissemination have been reported in patients with diabetes, hematologic malignancies, malnutrition, hypogammaglobulinemia and with the use of immunosuppressive drugs in autoimmune disease and organ transplantation (1,7,19). Patients with HTLV-1 are also at increased risk of Strongyloides infections because the virus increases interferon-gamma production and decreases IL-1, IL-3, IL-5 and IgE, which play an important role in parasitic defense (19).…”